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SUMMARY
Bone is the only body tissue capable of regeneration, allowing the restitutio ad integrum following trauma. In the event of a 
fracture or bone graft, new bone is formed, which following the remodeling process is identical to the pre-existing.
Bone is a dynamic tissue in constant formation and resorption. This balanced phenomena, known as the remodeling process, 
allows the renovation of 5-15% of the total bone mass per year under normal conditions (1). Bone remodeling consists of the 
resorption of a certain amount of bone by osteoclasts, likewise the formation of osteoid matrix by osteoblasts, and its sub-
sequent mineralization. This phenomenon occurs in small areas of the cortical bone or the trabecular surface, called “Basic 
Multicellular Units” (BMU).
Treatment in Traumatology, Orthopedics, Implantology, and Maxillofacial and Oral Surgery, is based on the biologic principals 
of bone regeneration, in which cells, extracellular matrix, and osteoinductive signals are involved.
The aim of this paper is to provide an up date on current knowledge on the biochemical and physiological mechanisms of bone 
regeneration, paying particular attention to the role played by the cells and proteins of the bone matrix.
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RESUMEN
El hueso es el único tejido del organismo capaz de regenerarse, permitiendo la restitutio ad integrum tras el trauma. Cuando 
se produce una fractura, se coloca un implante osteointegrado o se realiza un injerto para aumentar el sustrato óseo antes de la 
inserción de implantes, lo que se pretende es la regeneración ósea, es decir, la formación de hueso nuevo que, tras un proceso 
de remodelado, sea idéntico al preexistente.
El hueso es un tejido dinámico en constante formación y reabsorción. Este fenómeno equilibrado, denominado proceso de 
remodelado, permite la renovación de un 5-15 % del hueso total al año en condiciones normales (1). El remodelado óseo con-
siste en la reabsorción de una cantidad determinada de hueso llevada a cabo por los osteoclastos, así como la formación de la 
matriz osteoide por los osteoblastos y su posterior mineralización. Este fenómeno tiene lugar en pequeñas áreas de la cortical 
o de la superficie trabecular, llamadas “unidades básicas de remodelado óseo”.
La actuación terapéutica en los campos de la Traumatología y Ortopedia, Cirugía Oral y Maxilofacial e Implantología, se 
asienta sobre los principios biológicos de la regeneración ósea, en los que están implicados células, matriz extracelular y 
señales osteoinductivas. 
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INTRODUCTION
From the histological point of view, bone is a highly vascu-
larized and innervated, mineralized conjunctive tissue, which 
is structured in lamellae of calcified osteoid matrix. The 
arrangement of these lamellae determines whether the bone is 
cortical or cancellous. Both are composed of osteons. Cortical 
or compact bone, containing osteocytes, is arranged concentri-
cally around Haversian Canals. Cancellous or trabecular bone 
is formed by a network of bone lamellae, delimiting areolar 
cavities inside which the bone marrow is found (2). Both 
cortical and trabecular bone contain specialized cells, organic 
matrix and mineral phase.
1. Bone Cells
Various cell types co-exist in bone (table 1). Bone cells are 
found within the bone tissue itself or in the conjunctive stroma 
of the bone marrow, which is rich in mesenchymal stem cells. 
From the studies by Friedenstein in 1976 it is known that five 
distinct cell types can originate from these stem cells: fibro-
blasts, osteoblasts, chondroblasts, adipocytes and myoblasts 
(3), in response to different molecular signals which initiate 
the activation cascade of different genes.
1.1 – Osteoblastic differentiation
A/- Growth factors and genetics: It is currently known that the 
differentiation towards the osteoblastic line is controlled by 
genes related to the Hedgehog family, of which the most well 
known are: Ihh (Indian hedgehog) and Shh (Sonic hedgehog) 
(4,5). Also essential are the transcription factor Cbfa1 (core-
binding factor a-1, also known as Runx2) (6,7,8,9) and the 
bone morphogenetic proteins (BMPs), which constitute the 
most powerful regulators of osteoblastic differentiation from 
the mesenchymal stem cells (4).
B/- Differentiation markers: As the precursor cells differentiate 
they express proteins specific to their function, or markers, in 
the cellular membrane. The expression of Cbfa1 is the first 
indication of osteogenic differentiation (4), the maximum le-
vel of which is reached in the pre-osteoblasts. Collagen I and 
osteopontin (OPN) are expressed early on in osteoprogenitor 
cells. In the same way alkaline phosphatase (ALP) is a surface 
protein that could participate in the regulation of proliferation, 
migration and differentiation of the osteoblastic cells. Bone 
sialoprotein (BSP) and osteocalcin (OCN), are pre-osteoblast 
to osteoblast differentiation markers and appear when minera-
lization begins. The expression of these proteins is especially 
useful as osteogenic markers in the final stages of osteoblastic 
differentiation.
1.2 – The osteoblast
Osteoblasts are large cells (20-30 µm), in the form of a polyhe-
dron, with a basophilic cytoplasm, and with a substantial rough 
endoplasmic reticulum and Golgi apparatus. They originate 
from the mesenchymal stem cells of the bone marrow, endos-
teum, periosteum, and perivascular pericytes (10). They emit 
cytoplasmic processes towards the matrix, which communicate 
with the osteocyte network and neighbouring osteoblasts. The 
osteoblasts and the osteocytes communicate with each other 
by transmembrane proteins or integrins, which act as a link 
between cells or between a cell and the extracellular matrix, 
allowing the passage of messengers such as calcium, cytokines 
and prostaglandins. In these cells the intercellular connection 
is Connexin 43 (11).
The osteoblasts synthesize the organic matrix or osteoid mate-
rial at a rate of 2 to 3 µm per day, and express a characteristic 
enzyme, alkaline phosphatase (ALP), which permits minera-
lization at a rate of 1-2 µm per day. It is now known that they: 
1 - synthesize the collagen and non-collagen proteins of the 
organic bone matrix, 2 - direct the arrangement of the extrace-
llular matrix fibrils, 3 - contribute to the mineralization of the 
osteoid material, due to the alkaline phosphatase, 4 - mediate 
in the resorption carried out by the osteoclasts, through the 
synthesis of specific cytokines (12) and 5 - synthesize growth 
factors.
The average lifespan of human osteoblasts is from 1 to 10 wee-
ks, at the end of which they can disappear through apoptosis, 
become transformed into bone lining cells or into osteocytes 
(15%) (13). Both types of cells represent more advanced stages 
of maturation. The bone lining cells are elongated and flat, with 
spindle shaped nuclei, and scarce organelles. They can express 
the previously mentioned osteoblastic markers such as bone 
sialoprotein, osteopontin, osteonectin, and alkaline phosphatase 
as well as parathyroid hormone receptor (PTH). They remain 
along the endosteal surface, forming with the endosteum a 
protective layer to the bone surface, which plays an important 
role in the activation of bone remodeling.
1.3 – The osteocyte
Once the matrix is mineralized, some osteoblasts remain 
trapped within, becoming transformed into osteocytes. The 
osteoblasts, osteoclasts and bone lining cells are found on 
the bone surface, while the osteocytes are on the interior. The 
osteocytes are the most abundant cells in bone (10 times the 
osteoblasts). They are stellate and are found in the interior of 
lacunae, the cytoplasmic processes communicate with each 
other through bone canaliculi filled with extracellular bone 
fluid. In this way, the osteocytes organize themselves into a 
El objetivo de este trabajo es realizar una puesta al día de los conocimientos actuales sobre los mecanismos bioquímicos y 
fisiológicos de la regeneración ósea, resaltando de manera especial el papel que en ella juegan las células y las proteínas de 
la matriz ósea.
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syncytium of interconnected cells which forms a single struc-
ture, with the advantage that there is a large contact surface 
both on the inside and towards the bone surface, assuring the 
supply of oxygen and nutrients. When trauma occurs in the 
bone, the cessation in the blood supply causes hypoxia and 
necrosis of the osteocytes situated further than 0.1 mm from 
an intact capillary vessel (14).
The osteocytes also participate in the synthesis and mine-
ralization of the osteoid matrix, but it is believed that their 
principal function is to control bone remodeling, detecting the 
mechanical variations of the loads, a phenomena known as 
mechanotransduction (15).
Osteocytes constitute the final stage of the osteoblastic line and 
are incapable of self-renewal. They have the same markers as 
the osteoblasts, but also have a specific marker, CD44, a mem-
brane receptor, strongly expressed in osteocytes and negative 
in osteoblasts and bone lining cells.
1.4 – The osteoclast
Osteoclasts are the cells responsible for resorption. These 
are large cells (100 µm), multinucleate, rich in mitochondria 
and vacuoles. The osteoclasts contain tartrate-resistant acid 
phosphatase (TRAP), which permits the dephosphorylation of 
the proteins, the activity of which is used for its identification 
both in vivo and in vitro. In addition they possess receptors 
for calcitonin.
The osteoclasts originate from the bone marrow hematopoie-
tic stem cells known as ‘Granulocyte-Macrophage Colony-
Forming Units’ (GM-CFU), precursors of macrophages and 
monocytes (16).
Osteoclasts have two special features in the membrane: a ruffled 
border, where resorption takes place, and a clear area rich in 
microfilaments, with integrins that serve as an anchor to the 
matrix. To this end, the osteoclasts move towards the area to be 
resorbed and then immediately adhere to the mineralized bone 
surface with the ruffled border and sealing the edges of the area 
with the integrins. The osteoclast integrin, particularly avβ3, 
recognizes the Arg-Gly-Asp (RGD) sequence in the collagen 
and other proteins of the osteoid matrix. At this level the pH 
is acid since they secrete acids (H+) generated by carbonic 
anhydrase II and proteolytic enzymes such as collagenases, 
metalloproteases, cathepsin K, glucuronidase, etc. (16), which 
initiate bone resorption by the solubilization of first the organic 
and then the mineral matrix.
With respect to osteoclastogenesis, it is currently known that 
the osteoblasts are fundamental to the formation of osteoclasts. 
Thus, the Macrophage Colony-Stimulating Factor (M-CSF) 
produced by the osteoblasts is required in the early phases of 
osteoclastogenesis for the formation of giant multinucleate ce-
lls. Present knowledge on osteoclastogenesis regulation is based 
on the existence of 3 key molecules: OPG (osteoprotegerin, a 
soluble protein synthesized by osteoblasts and pre-osteoblasts), 
RANKL (a ligand situated on the surface of the osteoblasts and 
pre-osteoblasts), and RANK (a receptor of the above, situated 
on the osteoclast and pre-osteoclast membranes). The RANKL 
(receptor activator of NFkB ligand) previously called ODF 
(osteoclast differentiation factor) (12, 17) is a transmembrane 
cytokine belonging to the tumor necrosis factor family (TNF) 
(18). The interaction between RANKL and its receptor RANK 
initiates osteoclastic activity and differentiation, increasing 
resorption. Likewise, the effects of RANKL both in vivo and 
in vitro are inhibited by osteoprotegerin (OPG) a circulating 
protein belonging to the superfamily of TNF receptors (12).
When OPG and RANKL bind together, the union between 
RANK and RANKL is inhibited, and thus the osteoclastic 
differentiation is also inhibited. For this reason OPG, RANK 
and RANKL are important regulators of osteoclastogenesis.
2. Organic matrix
The organic matrix or osteoid material makes up a third of the 
bone mass. It is formed fundamentally by proteins, especially 
collagen (90%) (Table 2). The matrix plays an important role 
within the entire bone system, a fact which becomes evident 
when collagen disease, such as imperfect osteogenesis, appears. 
However, the extracellular mineralized matrix should now be 
considered as something more than simply a reservoir of calcium 
and phosphorous, since it constitutes a reserve of proteins that 
participate in the regulation of cellular differentiation and in the 
integrity and function of bone tissue (19).
A - Collagen
Ninety percent of the extracellular matrix (ECM) is made up 
of collagen, above all type I (>95%) and type V (<5%). The 
presence of small amounts of collagen type III has also been 
found, related to Sharpey fibers, and type XII, formed under 
mechanical stress. In the collagen molecule the Arg-Gly-Asp 
(RGD) sequence is found, which is recognised by the surface 
integrins of the bone cells (20). Characteristically they contain the 
hydroxylysine and hydroxyproline amino acids, the latter being 
a specific marker of all the collagen phenotypes and its urinary 
secretion values being directly related to the bone resorption rate 
(21). The collagen fibers are established by means of hydrogen 
bridges between amino acids and through the formation of pyri-
dinoline bridges between lysines and hydroxylysines. However, 
collagen has no great affinity for calcium, for this reason other 
proteins are involved in mineral deposition.
B - Non-collagen proteins: Among which are highlighted:
B.1 – Proteoglycans: are large molecules and make up 10% of 
the non-collagen proteins. In the osteoid matrix there are four 
types of proteoglycans: Hyaluronan and chondroitin-sulphate: 
are large molecules, and take part in the initial stages of bone 
morphogenesis. Biglycan and decorin: are smaller molecules, 
and appear in the next phases of bone formation.
B.2 – Proteins with γ-carboxyglutamic acid: These are osteo-
calcin (OCN) and the matrix protein with  γ-carboxyglutamic 
acid. This is an amino acid which binds calcium and requires 
vitamin K for its synthesis.
BONE MARROW STROMA  BONE TISSUE 
Hemopoietic Stem cells Osteoblasts 




Endothelial cells Linfoid cells 
Table 1. Bone cells
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Osteocalcin is a small matrix protein synthesized by osteoblasts 
and platelets. Dependent on vitamins D and K, it represents 
15% of the non-collagen matrix proteins and contains 3 mole-
cules of γ-carboxyglutamic acid. Its plasmatic levels have been 
considered as one of the biochemical markers of osteogenesis, 
being related with the number and activity of the osteoblasts.
B.3 – Glycoproteins: These are osteonectin, alkaline phospha-
tase, and proteins with the RGD tripeptide (Arg-Gly-Asp).
Osteonectin is a glycoprotein with a strong affinity for collagen 
type I, calcium and hydroxyapatite. It represents 25% of the 
non-collagen proteins. It is thought to play a role in the regu-
lation of cellular adhesion between the matrix and the cells. In 
bone it is necessary for normal mineralization.
Alkaline phosphatase is an enzyme that liberates inorganic 
phosphate from phosphoric esters, and is necessary for mine-
ralization. Various isoenzymes exist; the bone one is considered 
a good marker of osteoblastic activity.
There are fundamentally five proteins with the RGD tripeptide, 
also called SIBLINGS (Small Integrin-Binding Ligand, N-
linked Glycoprotein): osteopontin, bone sialoprotein, fibrone-
ctin, thrombospondin and vitronectin. These glycoproteins are 
fundamental to bone regeneration and remodeling processes, 
with an Arg-Gly-Asp (RGD) sequence which is recognized by 
the osteoblast and osteoclast integrins (avβ3, among others). 
They also act as bone cell surface receptors, allowing the ad-
hesion of the cells to the extracellular matrix, and activating 
signals.
B.4 – Proteins originating from plasma: a greater proportion 
of these are found in the organic bone matrix than in plasma. 
They are albumin and a2-SH-glycoprotein, probably related 
with the deposition of calcium in the osteoid matrix.
B.5 – Growth factors: these are polypeptides, synthesized 
within the bone itself or derived from other locations (liver, 
platelets, etc.), and which take part in the autocrine or paracri-
ne differentiation, growth and proliferation of the cells (table 
2) (22).
3. Mineral phase
Finally, the mineral component of bone represents 65% of the 
bone mass. It is formed by calcium, phosphate and carbonate 









 and, in smaller quantities, mag-
nesium, sodium, potassium, manganese and fluoride. The 
plasma is supersaturated with calcium and phosphorous with 
respect to hydroxyapatite, so there must be substances which 
inhibit mineralization. The proteins with adhesive capacity 
favor mineralization, while the proteoglycans, magnesium, 
ATP and pyrophosphates act as inhibitors.
4. Bone regeneration
Tissue regeneration is the solution achieved by the restitutio 
ad integrum of tissue following trauma, in contrast to repair, 
where scar tissue is formed having different characteristics 
from the original. In this regard, bone is the only tissue in 
the body, with the exception of embryonic, which is fully 
restored following an injury (1). Bone regeneration creates a 
response in which blood vessels, cells and extracellular matrix 
are involved. The importance of blood vessels in osteogenesis 
is known from studies by Trueta (23). Following trauma, an 
inflammatory response and an initial hematoma is produced, 
with red blood cells, platelets and fibrin. The cells release 
interleukins and growth factors, setting off the migration of 
lymphocytes, macrophages, osteoclast precursors and stem 
cells. These molecular signals promote the differentiation 













� proteins with RGD: 
                                     - fibronectin 
                                     - thrombospondin 
                                     - osteopontin 
                                     - vitronectin 
                                     - bone sialoprotein 
PROTEINS FROM PLASMA � Albumin
� �2-SH- glycoprotein 
GROWTH FACTORS 
� IGF-I, II 
� TGF-�
� PDGF
Table  2. Osteoid matrix proteins
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towards endothelial cells, fibroblasts, chondroblasts and oste-
oblasts, creating a new fibrovascular tissue which replaces the 
initial coagulate. This is all regulated by a series of complex 
interactions between growth factors, hormones and cytokines. 
The vascular supply, proteic synthesis and mineralization are 
all fundamental to this process.
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